logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ASH 2018 — Ixazomib extends post-ASCT PFS in multiple myeloma

TOURMALINE-MM3 trial supports efficacy of ixazomib maintenance posttransplant.